Mayfair Advisory Group’s AbbVie ABBV Stock Holding History

Mayfair Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$470K	Sell	1,812 -6	-0.3%	-$1.29K	0.14%	110
2026 Q1	$395K	Sell	1,818 -2	-0.1%	-$444	0.14%	118
2025 Q4	$417K	Sell	1,820 -120	-6%	-$27.3K	0.16%	113
2025 Q3	$449K	Buy	1,940 +23	+1%	+$4.68K	0.19%	95
2025 Q2	$380K	Sell	1,917 -83	-4%	-$15.4K	0.18%	106
2025 Q1	$419K	Buy	2,000 +280	+16%	+$54.4K	0.24%	80
2024 Q4	$306K	Buy	1,720 +100	+6%	+$18.4K	0.18%	105
2024 Q3	$315K	Hold	1,620	–	–	0.2%	98
2024 Q2	$276K	Hold	1,620	–	–	0.19%	108
2024 Q1	$295K	Buy	1,620 +100	+7%	+$17.2K	0.21%	100
2023 Q4	$243K	Hold	1,520	–	–	0.21%	104
2023 Q3	$226K	Hold	1,520	–	–	0.22%	107
2023 Q2	$206K	Hold	1,520	–	–	0.21%	117
2023 Q1	$246K	Buy	1,520 +37	+2%	+$5.66K	0.27%	94
2022 Q4	$240K	Buy	+1,483	New	+$227K	0.31%	92
2022 Q2	–	Sell	-1,350	Closed	-$220K	–	118
2022 Q1	$220K	Buy	+1,350	New	+$196K	0.28%	98
2021 Q4	–	Sell	-2,017	Closed	-$219K	–	99
2021 Q3	$219K	Hold	2,017	–	–	0.34%	85
2021 Q2	$227K	Hold	2,017	–	–	0.36%	79
2021 Q1	$219K	Sell	2,017 -43	-2%	-$4.6K	0.39%	77
2020 Q4	$221K	Buy	+2,060	New	+$198K	0.43%	73

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Mayfair Advisory Group's ABBV Position: Q2 2026 in Review

Mayfair Advisory Group reduced its AbbVie (ABBV) stake by 0.33% in Q2 2026, selling an estimated $1.29K and leaving 1,812 shares worth $470K. The position accounts for 0.14% of the portfolio, ranked #110.

Mayfair Advisory Group first reported a position in ABBV in Q4 2020 and has held it in 20 quarters since. 3,232 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Mayfair Advisory Group held 1,812 shares of AbbVie worth $470K as of Q2 2026.
Mayfair Advisory Group sold 6 AbbVie shares in Q2 2026, an estimated $1.29K.
AbbVie made up 0.14% of Mayfair Advisory Group's portfolio in Q2 2026, its #110 holding.
Mayfair Advisory Group first reported a position in AbbVie in Q4 2020 and has held it in 20 quarters since.
3,232 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mayfair Advisory Group's 13F filing for Q2 2026, filed 11 Aug 2026.